News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|March 25, 2022

Considerations for Moderna's move to get an EUA for the COVID-19 vaccine in young kids

Author(s)Miranda Hester

Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.

Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Dexcom Stelo cleared as first OTC continuous glucose monitor for children Credit: US Food and Drug Administration

Dexcom Stelo cleared as first OTC continuous glucose monitor for children

ByPatrick Campbell

June 12th 2026

ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza

ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza

ByKevin Kunzmann,Morgan Ebert, Executive Editor

June 11th 2026

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

ByMorgan Ebert, Executive Editor

June 10th 2026

FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease

FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease

ByMorgan Ebert, Executive Editor

June 10th 2026

FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis

FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis

ByMorgan Ebert, Executive Editor

June 10th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Handheld optical device detects necrotizing enterocolitis in premature infants before radiographic signs appear

ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

Dexcom Stelo cleared as first OTC continuous glucose monitor for children

Weekly review: Mental health concerns, FDA approvals, and more